Donna Ludwinski has a vast knowledge of the neuroblastoma research landscape.

As a staunch parent advocate, Donna is passionate about providing resources to neuroblastoma families and guiding them through the world of clinical trials to empower their decision-making. She is based in New York, USA, and is the Director of Research Programs for Solving Kids' Cancer in the US.

Donna is an active member of the New Approaches to Neuroblastoma Therapy (NANT) Advisory Council, Coalition Against Childhood Cancer (CAC2) Board, and National Cancer Institute (NCI) Pediatric Central Institutional Review Board. She is also a member of the American Association for Cancer Research (AACR) Pediatric Cancer Working Group (PCWG) and was a member of their Steering Committee 2015-2018. Donna also serves on the Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (PedsODAC) for the US Food and Drug Administration (FDA).

Donna’s son, Erik, passed from neuroblastoma in 2010 at the age of 24.